1. Ballabriga, et al. Review of hybrid pixel detector readout ASICs for spectroscopic X-ray imaging. J. Instrum. 11, P01007–P01007 (2016). https://doi.org/10.1088/1748-0221/11/01/P01007
2. Taguchi, K. & Iwanczyk, J. S. Vision 20/20: Single photon counting X-ray detectors in medical imaging. Med. Phys. 40, 100901 (2013). https://doi.org/10.1118/1.4820371
3. Bahadur, D. et al. Evolution of structure and dynamics of thermo-reversible nanoparticle gels-A combined XPCS and rheology study. J. Chem. Phys. 151, 10 (2019). https://doi.org/10.1063/1.5111521
4. Sheyfer, et al.Nanoscale critical phenomena in a complex fluid studied by X-ray photon correlation spectroscopy.Phys. Rev. Lett. 125, 125504 (2020). https://doi.org/10.1103/PhysRevLett.125.125504
5. Szczygiel, R., Grybos, P., Maj, P. & Zoladz, M. PXD18k - Fast Single Photon Counting Chip with Energy Window for Hybrid Pixel Detector. in 2011 IEEE Nuclear Science Symposium Conference Record. 932–937 (IEEE, Valencia, Spain 2011). https://doi.org/10.1109/NSSMIC.2011.6154126
6. Nilsson, H. E., Dubari, E., Hjelm, M. & Bertilsson, K. Simulation of photon and charge transport in x-ray imaging semiconductor sensors. Nucl. Instrum. Methods Phys. Res. A. 487, 151–162 (2002). https://doi.org/10.1016/S0168- 9002(02)00959-2
7. Ballabriga, R. et al. The Medipix3RX: a high resolution, zero dead-time pixel detector readout chip allowing spectroscopic imaging. Instrum. 8, C02016–C02016 (2013). https://doi.org/10.1088/1748-0221/8/02/C02016
8. Krzyzanowska, A. et al. Characterization of the photon counting CHASE Jr., chip built in a 40-nm CMOS process with a charge-sharing correction algorithm using a collimated X-ray beam. IEEE Trans. Nucl. Sci. 64, 2561–2568 (2017). https://doi.org/10.1109/TNS.2017.2734821
9. Bellazzini, R. et al. PIXIE III: a very large area photon-counting CMOS pixel ASIC for sharp X-ray spectral imaging. J. Instrum. 10, C01032–C01032 (2015). https://doi.org/10.1088/1748-0221/10/01/C01032
10. Otfinowski, P. et al. Comparison of allocation algorithms for unambiguous registration of hits in presence of charge- sharing in pixel detectors. J. Instrum. 12, C01027–C01027 (2017). http://doi.org/10.1088/1748-0221/12/01/C01027
11. Otfinowski, P., Deptuch, G. W. & Maj, P. Asynchronous approximation of a center of gravity for pixel detectors’ readout circuits. IEEE Solid-State Circuits 53, 1550–1558 (2018). https://doi.org/10.1109/JSSC.2018.2793530
12. Cartier, et al. Micron resolution of MÖNCH and GOTTHARD, small pitch charge integrating detectors with single photon sensitivity. J. Instrum. 9, C05027–C05027 (2014). https://doi.org/10.1088/1748-0221/9/05/C05027
13. Dreier, E. S. et al. Virtual subpixel approach for single-mask phase-contrast imaging using Timepix3. J. Instrum. 14, C01011 (2019). https://doi.org/10.1088/1748-0221/14/01/C01011
14. Maj, P. et al. Measurements of ultra-fast single photon counting chip with energy window and 75 μm pixel pitch with Si and CdTe J. Instrum. 12, C03064 (2017). https://doi.org/10.1088/1748-0221/12/03/C03064
15. Krzyzanowska, A., Niedzielska, A. & Szczygieł, R. Charge-sharing simulations for new digital algorithms achieving subpixel resolution in hybrid pixel detectors. J. Instrum. 15, C02047 (2020). https://doi.org/10.1088/1748- 0221/15/02/C02047
16. Lutz, Semiconductor Radiation Detectors, Device Physics. (Berlin, Heidelberg: Springer Berlin Heidelberg, 2007).
17. NIST XCOM: Photon Cross Sections Database – Introduction. NIST http://www.physics.nist.gov/PhysRefData/Xcom/Text/intro.html (2017).
18. Otfinowski, A. et al. Pattern recognition algorithm for charge-sharing compensation in single photon counting pixel detectors. J. Instrum. 14, C01017 (2019). https://doi.org/10.1088/1748-0221/14/01/C01017

1. Bouchnita A., Eymard N., Moyo T.K., Koury M.J., Volpert V.: Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis. Am J Hematol. 2016; 91 (4): 371– 378. doi: 10.1002/ajh.24291.
2. Wang Y., Gao A., Zhao H., et al.: Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1alpha/CCL3. Leukemia. 2016; 30 (9): 1897–1908. doi: 10.1038/leu.2016.81.
3. Bohlius J., Bohlke K., Castelli R., et al.: Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update. J Clin Oncol. 2019; 37 (15): 1336–1351. doi: 10.1200/JCO.18.02142.
4. Schiffer C.A., Bohlke K., Delaney M., et al.: Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018; 36 (3): 283–299. doi: 10.1200/JCO.2017.76.1734.
5. Drozd-Sokolowska J.E., Wiktor-Jedrzejczak W.: Factors determining the risk of severe (WHO grades 3 and 4) hemorrhage in hematologic patients. Transfus Apher Sci. 2011; 44: 129–134. doi: 10.1016/j. transci.2011.01.004.
6. Rodgers G.M., Gilreath J.A., Alwan L., et al.: Cancer- and Chemotherapy Induced Anemia. NCCN Clinical Practice Guidelines in Oncology. https://www.nccn.org/professionals/physician_gls/f_guidelines. asp#anemia: NCCN; 2016.
7. Laszlo D., Agazzi A., Goldhirsch A., et al.: Tailored therapy of adult acute leukaemia in Jehovah’s Witnesses: unjustified reluctance to treat. Eur J Haematol. 2004; 72 (4): 264–267. doi: 10.1111/ j.0902-4441.2003.00211.x.
8. Chojnowski K., Janus A., Blizniewska K., Robak M., Trelinski J.: Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah’s Witness patient. Transfusion. 2016; 56 (10): 2438–2442. doi: 10.1111/trf.13703.
9. Mazza P., Palazzo G., Amurri B., Cervellera M., Rizzo C., Maggi A.: Acute leukemia in Jehovah’s Witnesses: a challenge for hematologists. Haematologica. 2000; 85: 1221–1222.
10. Brown N.M., Keck G., Ford P.A.: Acute myeloid leukemia in Jehovah Witnesses. Leuk Lymphoma. 2008; 49 (4): 817–820. doi: 10.1080/10428190801911670.
11. Cullis J.O., Duncombe A.S., Dudley J.M., Lumley H.S., Apperley J.F., Smith A.G.: Acute leukaemia in Jehovah’s Witnesses. Br J Haematol. 1998; 100 (4): 664–668. doi: 10.1046/j.1365-2141.1998.00634.x.
12. Wilop S., Osieka R.: Antineoplastic chemotherapy in Jehovah’s Witness patients with acute myelogenous leukemia refusing blood products — a matched pair analysis. Hematology. 2018; 23 (6): 324–329. doi: 10.1080/10245332.2017.
13. Ford P.A., Grant S.J., Mick R., Keck G.: Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah’s Witnesses. J Clin Oncol. 2015; 33 (15): 1674–1679. doi: 10.1200/JCO.2014.57.9912.
14. Agapidou A., Vakalopoulou S., Papadopoulou T., Chadjiaggelidou C., Garypidou V.: Successful Treatment of Severe Anemia using Erythropoietin in a Jehovah Witness with Non-Hodgkin Lymphoma. Hematol Rep. 2014; 6 (4): 5600. doi: 10.4081/hr.2014.5600.
15. Yamamoto Y., Kawashima A., Kashiwagi E., Ogata K.: A Jehovah’s Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions. Case Rep Hematol. 2014; 2014: 141260. doi: 10.1155/2014/141260.
16. Garelius H., Grund S., Stockelberg D.: Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah’s Witness with acute monocytic leukemia. Clin Case Rep. 2015; 3 (5): 287–290. doi: 10.1002/ccr3.212.
17. Bareford D., Odeh B., Narayanan S., Wiltshire S.: Remission induction in a Jehovah’s witness patient with acute myeloid leukaemia using gemtuzumab ozogamicin. Transfus Med. 2005; 15 (5): 445–448. doi: 10.1111/j.1365-3148.2005.00611.x.
18. Fujisawa S., Naito K., Matsuoka T., Kobayashi M.: Complete remission induced by gemtuzumab ozogamicin in a Jehovah’s Witness patient with acute myelogenous leukemia. Int J Hematol. 2007; 85 (5): 418–420. doi: 10.1532/IJH97.07018.
19. Donahue L.L., Shapira I., Shander A., Kolitz J., Allen S., Greenburg G.: Management of acute anemia in a Jehovah’s Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin- based oxygen carrier: a case report and review of literature. Transfusion. 2010; 50 (7): 1561– 1567. doi: 10.1111/j.1537-2995.2010.02603.x.